TCIM
DCPH

TIAA CREF Investment Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

TIAA CREF Investment Management’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$411K Hold
17,716
– – ﹤0.01% 2666
2018
Q4 		$372K Buy
17,716
+2,577
+17% +$63.4K ﹤0.01% 2690
2018
Q3 		$586K Sell
15,139
-703
-4% -$26K ﹤0.01% 2656
2018
Q2 		$623K Buy
15,842
+2,134
+16% +$62.8K ﹤0.01% 2683
2018
Q1 		$275K Buy
13,708
+2,353
+21% +$59.6K ﹤0.01% 2920
2017
Q4 		$257K Buy
+11,355
New +$222K ﹤0.01% 2968

Other funds holding DCPH

NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TIAA CREF Investment Management's DCPH Position: Q1 2019 in Review

TIAA CREF Investment Management held its Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) position steady in Q1 2019 at 17,716 shares worth $411K. The position accounts for ﹤0.01% of the portfolio, ranked #2666.

TIAA CREF Investment Management first reported a position in DCPH in Q4 2017 and has held it in 6 quarters since. The position peaked at $623K in Q2 2018. 80 funds tracked by Wall St. Rank hold DCPH as of Q1 2019.

  • TIAA CREF Investment Management held 17,716 shares of Deciphera Pharmaceuticals, Inc. Common Stock worth $411K as of Q1 2019.
  • TIAA CREF Investment Management left its Deciphera Pharmaceuticals, Inc. Common Stock share count unchanged in Q1 2019.
  • Deciphera Pharmaceuticals, Inc. Common Stock made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #2666 holding.
  • TIAA CREF Investment Management first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2017 and has held it in 6 quarters since.
  • TIAA CREF Investment Management's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $623K in Q2 2018.
  • 80 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.